ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 41 filers reported holding ATYR PHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $117,000 | – | 23,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $6,215,000 | 6.43% |
| EcoR1 Capital, LLC | 2,292,659 | $7,795,000 | 1.38% |
| Rock Springs Capital Management LP | 475,000 | $1,615,000 | 0.08% |
| Quotient Investors, LLC | 22,200 | $77,000 | 0.06% |
| Alyeska Investment Group, L.P. | 839,264 | $2,853,000 | 0.02% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $275,000 | 0.01% |
| Glen Harbor Capital Management LLC | 153,238 | $529,000 | 0.01% |
| Elkfork Partners LLC | 99,154 | $342,000 | 0.01% |
| Meadow Creek Investment Management LLC | 126,196 | $435,000 | 0.01% |
| Tyers Asset Management LLC | 72,112 | $249,000 | 0.01% |